• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Protonstatin-1

CAS No. 521972-99-6

Protonstatin-1 ( —— )

产品货号. M36384 CAS No. 521972-99-6

Protonstatin-1 is used as a hypoglycemic agent and as a compound for the treatment of Alzheimer's disease, inhibits IGFIR kinase activity and can be used in cancer research.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥2519 有现货
5MG ¥3553 有现货
10MG ¥5233 有现货
25MG ¥7718 有现货
50MG ¥10870 有现货
100MG ¥14306 有现货
500MG ¥28535 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Protonstatin-1
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Protonstatin-1 is used as a hypoglycemic agent and as a compound for the treatment of Alzheimer's disease, inhibits IGFIR kinase activity and can be used in cancer research.
  • 产品描述
    Protonstatin-1 is used as a hypoglycemic agent and as a compound for the treatment of Alzheimer's disease, inhibits IGFIR kinase activity and can be used in cancer research.
  • 体外实验
    ——
  • 体内实验
    ——
  • 同义词
    ——
  • 通路
    Angiogenesis
  • 靶点
    IGF-1R
  • 受体
    IGF-1R
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    521972-99-6
  • 分子量
    211.26
  • 分子式
    C8H5NO2S2
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    O=C1NC(=S)S\C1=C/C1=CC=CO1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

产品手册
关联产品
  • LMPTP INHIBITOR 1 hy...

    LMPTP INHIBITOR 1 是低分子量蛋白酪氨酸磷酸酶 (LMPTP) 的选择性抑制剂,IC50 为 0.8 μM LMPTP-A。

  • GIP (3-42), human

    GIP (3-42), human 充当葡萄糖依赖性促胰岛素多肽 (GIP) 受体拮抗剂,在体内调节胰岛素分泌和 GIP 的代谢作用。

  • KW-2450 free base

    KW-2450 free base is an orally bioavailable inhibitor of insulin-like growth factor 1 receptor (IGF-1R) and insulin receptor (IR) tyrosine kinases with potential antineoplastic activity. IGF-1R/IR inhibitor KW-2450 free base selectively binds to and inhibits the activities of IGF-1R and IR, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. IGF-R1 and IR tyrosine kinases, overexpressed in a variety of human cancers, play significant roles in the stimulation of cellular proliferation, oncogenic transformation, and suppression of apoptosis.